MET and non-small cell lung carcinoma: Initially discovered in familial and sporadic papillary renal carcinomas [114], subsequent studies revealed the incidence of MET alterations in SCLC and NSCLC, especially MET exon 14 skipping as identified initially by our laboratory [115,116].